Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

BACKGROUND: High ERCC1 expression is thought to be related with resistance to chemotherapy based on platinum. The aim of this study was to present our institutional observations regarding to the association of ERCC1 and overall survival (OS) of the lung adenocarcinoma patients who received chemother...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diagn Pathol
Autori principali: Piljić Burazer, Marina, Mladinov, Suzana, Matana, Antonela, Kuret, Sendi, Bezić, Joško, Glavina Durdov, Merica
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745063/
https://ncbi.nlm.nih.gov/pubmed/31521181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-019-0885-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi